Points out at the end of 2022, unlisted investments accounted for $8.3 million out of its total portfolio of $38.7 million, with Allied Gold making up the majority of the unlisted portion. - Braveheart Investment Group PLC - Barnsley, South Yorkshire-based investor in small- and medium-sized businesses - Provides update on two companies within its investment portfolio, Paraytec Ltd and Kirkstall Ltd. Notes Paraytec - 100% owned - is progressing with a clinical study to develop rapid tests for identifying cancer and pathogens, including viruses. Says initial results to compare performance of Paraytec's CX300 instrument with PCR tests indicate up to 100% correlation with patients who tested positive by PCR. The independent clinical statistical analysis and report is expected to be completed in June, at which time a further update will be provided.